Stay updated on Brilacidin Efficacy in COVID-19 Hospitalized Clinical Trial
Sign up to get notified when there's something new on the Brilacidin Efficacy in COVID-19 Hospitalized Clinical Trial page.

Latest updates to the Brilacidin Efficacy in COVID-19 Hospitalized Clinical Trial page
- Check2 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA site-wide NIH notice about terminology and website updates appears above the error page, and the footer revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check30 days agoChange DetectedThe page remains a 403 Forbidden error page, and its footer revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check44 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study results, with a Home link visible, indicating access to the content is blocked.SummaryDifference23%

- Check51 days agoChange DetectedThe page shows Revision: v3.7.0, replacing the previous revision tag. This denotes a newer version of the page, with no visible changes to the study results content.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page's revision line updated from v3.6.5 to v3.6.6, indicating a minor update to the Study Results page.SummaryDifference0.0%

Stay in the know with updates to Brilacidin Efficacy in COVID-19 Hospitalized Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brilacidin Efficacy in COVID-19 Hospitalized Clinical Trial page.